Distinct Gut Microbiota in Patients with Asymptomatic Hyperuricemia: A Potential Protector against Gout Development

PURPOSE: Here, we aimed to elucidate the differences in microbiota composition between patients with gout and those with asymptomatic hyperuricemia (asHU) and determine the effect of uric acid-lowering therapy (ULT) on the gut microbiome. MATERIALS AND METHODS: Stool samples from patients with asHU...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Hye Won, Yoon, Eun-Jeong, Jeong, Seok Hoon, Park, Min-Chan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Yonsei University College of Medicine 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8860935/
https://www.ncbi.nlm.nih.gov/pubmed/35184426
http://dx.doi.org/10.3349/ymj.2022.63.3.241

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8860935/
https://www.ncbi.nlm.nih.gov/pubmed/35184426
http://dx.doi.org/10.3349/ymj.2022.63.3.241

Ejemplares similares